杏仁医生 (established September 2014) is a doctor‑focused mobile medical app that positions physicians as the core users, offering WeChat-integrated tools, post-visit consultation workflows, and a social/operational ecosystem for doctors. The product emphasizes building doctor–patient trust through reliable face-to-face data and ongoing consultation services, and it includes operational features such as anonymized phone calls and promotional engagement activities. Within 10 months of launch the platform had authenticated more than 130,000 doctors, becoming one of China’s largest doctor‑specific platforms. 杏仁医生 has also introduced the U.S. UpToDate clinical advisor to support clinicians' decision-making. The company says it will use new funding to upgrade technology, iterate new products, and accelerate market expansion and strategic innovation.

Total raised

$32M

Funding rounds

1

Latest round

Series B

Latest activity

Jul 2015